Impact of orlistat therapy on weight reduction in morbidly obese patients after implantation of the Swedish adjustable gastric band

Obesity Surgery

Volumn 12, Issue 1, 2002, Pages 113-117

  Zoss, Isabelle ^a   Piec, Grazyna ^a   Horber, Fritz F ^a  

^a KLINIK HIRSLANDEN   (Switzerland)

Author keywords

Bariatric surgery; Gastric banding; Morbid obesity; Orlistat; Weight loss

Indexed keywords

TETRAHYDROLIPSTATIN;

ADULT; BODY MASS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; COUNSELING; DIET THERAPY; GASTRIC BANDING; GASTROINTESTINAL SYMPTOM; HUMAN; MORBID OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; FEMALE; GASTROPLASTY; HUMANS; LACTONES; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD; WEIGHT LOSS;

EID: 0036175011     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089202321144685     Document Type: Article

References (17)

1. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
2. Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials
3. A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention
4. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
5. Effect of sibutramine on weight maintenance after weight loss: A randomized trial
6. Long-term maintenance of weight loss after a very-low-calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine
7. Late outcome of isolated gastric bypass
8. Outcome after laparoscopic Roux-en-Y gastric bypass for morbid obesity
9. Vertical gastroplasty: Evolution of vertical banded gastroplasty
10. Silicone gastric banding: A simple and effective operation for morbid obesity
11. Balloon band for the treatment of massive obesity
12. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers
13. Treatment of morbid obesity with the Swedish adjustable gastric band (SAGB): Complication rate during a 12-month follow-up period
14. Biliopancreatic diversion
15. Biliopancreatic diversion with duodenal switch